Tafero

Tafero 25 mg

Tafero 25 mg (Tenofovir Alafenamide) belongs to the class of anti-viral medications employed for managing human immunodeficiency virus (HIV) type 1 and Chronic Hepatitis B Viral (HBV) infections. Tafero 25 mg (Tenofovir Alafenamide) has many benefits including,

• Prevention or slowing down of duplication process of the viruses
• Decreasing the proliferation of new viral cells in the system
• Clears the viral load from the system
• Increases the immunity power by enabling the growth of white blood cells (CD4) which protects against infection
• High efficiency with ten times lower dose than Tenofovir Disoproxil Fumarate

Administration of Tafero 25 mg (Tenofovir Alafenamide):

 Tafero 25 mg (Tenofovir Alafenamide) dosage in different populations:

Mild, moderate, or severe kidney impairments: 1 tablet of 25 mg once daily

End-stage kidney disease: Not recommended

Mild liver impairments:  1 tablet of 25 mg once daily

Decompensated (without a functional system) liver disease: Not recommended

Side-effects of Tafero 25 mg (Tenofovir Alafenamide):

Common side-effects:

• Headache
• Tiredness (Fatigue)
• Nausea
• Pain in the stomach region and back
• Cough

Severe side-effects:

Note: Please discuss with your doctor regarding the side-effects of Tafero 25 mg (Tenofovir Alafenamide) for more information.

Warnings associated with Tafero 25 mg (Tenofovir Alafenamide):

1. Discontinuation of treatment leading to severe acute liver complications: Patients are strictly forbidden to stop their current dosing schedule as such decisions could cause severe problems in the liver.
2. Risk of developing HIV-1 resistance in patients with HIV-1 coinfection: If patients already have HIV infection and have not received any cure, this drug might increase resistance to HIV medications.
3. New onset or worsening condition of the kidney: If patients have any sort of problems in the kidney (end-stage renal disease), avoid using tenofovir-based medications for decreasing any chances of acute kidney failure.
4. Missed dosage leading to resistance: Patients should take the dosage as prescribed by their doctor. If patients miss even a single dose, the viral cells may develop resistance against Tafero 25 mg (Tenofovir alafenamide).
5. Drug interactions: Patients are obliged to inform about all medicines they are taking other than Tafero 25 mg (Tenofovir alafenamide).
6. Pregnancy-related issues: Discuss the pregnancy and breastfeeding issues with your doctor.